216 related articles for article (PubMed ID: 15999918)
21. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
22. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
24. Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.
Fujii H; Matsuyama A; Komoda H; Sasai M; Suzuki M; Asano T; Doki Y; Kirihata M; Ono K; Tabata Y; Kaneda Y; Sawa Y; Lee CM
Radiat Oncol; 2011 Jan; 6():8. PubMed ID: 21247507
[TBL] [Abstract][Full Text] [Related]
25. Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan.
Lan TL; Chou FI; Lin KH; Pan PS; Lee JC; Huang WS; Liu YM; Chao Y; Chen YW
Appl Radiat Isot; 2020 Jun; 160():109105. PubMed ID: 32351215
[TBL] [Abstract][Full Text] [Related]
26. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
[TBL] [Abstract][Full Text] [Related]
27. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
28. Boron neutron capture therapy: preliminary study of BNCT with sodium borocaptate (Na2B1 2H1 1SH) on glioblastoma.
Takagaki M; Oda Y; Miyatake S; Kikuchi H; Kobayashi T; Sakurai Y; Osawa M; Mori K; Ono K
J Neurooncol; 1997 Nov; 35(2):177-85. PubMed ID: 9266456
[TBL] [Abstract][Full Text] [Related]
29. Boron neutron capture therapy for newly diagnosed glioblastoma.
Kawabata S; Miyatake S; Kuroiwa T; Yokoyama K; Doi A; Iida K; Miyata S; Nonoguchi N; Michiue H; Takahashi M; Inomata T; Imahori Y; Kirihata M; Sakurai Y; Maruhashi A; Kumada H; Ono K
J Radiat Res; 2009 Jan; 50(1):51-60. PubMed ID: 18957828
[TBL] [Abstract][Full Text] [Related]
30. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
31. Clinical results of boron neutron capture therapy (BNCT) for glioblastoma.
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2011 Dec; 69(12):1823-5. PubMed ID: 21684170
[TBL] [Abstract][Full Text] [Related]
32. An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme.
Pellettieri L; H-Stenstam B; Rezaei A; Giusti V; Sköld K
Acta Neurol Scand; 2008 Mar; 117(3):191-7. PubMed ID: 18297764
[TBL] [Abstract][Full Text] [Related]
33. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
Verbakel WF; Sauerwein W; Hideghety K; Stecher-Rasmussen F
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):743-56. PubMed ID: 12573762
[TBL] [Abstract][Full Text] [Related]
34. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
35. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
36. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
37. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
[TBL] [Abstract][Full Text] [Related]
38. Neuropathological postmortem evaluation of BNCT for GBM.
H-Stenstam B; Pellettieri L; Sköld K; Rezaei A; Brun A
Acta Neurol Scand; 2007 Sep; 116(3):169-76. PubMed ID: 17714330
[TBL] [Abstract][Full Text] [Related]
39. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
40. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
